The Power Of Clinical Trial Supply Visibility

Over the last few years the number of innovative drugs brought to market has declined as pharmaceutical companies have focussed their resources on improvements to existing drugs or expanding their off-label use.

In part, the evolution of this trend can be traced to the advent of corporate mergers between pharmaceutical companies which has left much of the innovation gap in new medications to be filled by biopharma. Indeed, it is from these relatively small companies that the majority of new products and innovations have emerged in recent years…

Read more about this here

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients